Cystic Fibrosis
The latest news about Cystic Fibrosis: headlines, AI summaries and the full story from every source.
- Arcturus Therapeutics Reports Q3 2026 Results with Narrowing Net Loss and Strong Cash Position
- Vertex Pharmaceuticals Reports Q3 2026 Revenue Growth and Raises Full-Year Guidance
- Vertex Pharmaceuticals Reports 12% Revenue Growth Driven by Alyftrek Transition
- Cystic Fibrosis: The Remaining 10% Still Lack Effective Treatments
- Vertex Acquires Crinetics in $10 Billion Deal for Expansion into Endocrinology
- Vertex Pharmaceuticals Exceeds Profit Estimates as Sales of New Cystic Fibrosis Drug Surge
- RBC Raises Price Target for Vertex Pharmaceuticals Amid Biotech Sector Outlook Update